EXOC7
protein-codingexocyst complex component 7, the group of Exocyst complex|MicroRNA protein coding host genes
Gene summary
The protein encoded by this gene is a component of the exocyst complex. The exocyst complex plays a critical role in vesicular trafficking and the secretory pathway by targeting post-Golgi vesicles to the plasma membrane. The encoded protein is required for assembly of the exocyst complex and docking of the complex to the plasma membrane. The encoded protein may also play a role in pre-mRNA splicing through interactions with pre-mRNA-processing factor 19. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 4. [provided by RefSeq, Nov 2011]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~40.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0033658
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0033658
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0033658
Submitter: ClinGen
*EXOC7* encodes a component of the exocyst complex that mediates fusion of intracellular vesicles to the plasma membrane during exocytosis and is highly expressed in the developing human cortex. *EXOC7* was first reported in relation to autosomal recessive neurodevelopmental disorder with seizures and brain atrophy in 2020 (Coulter et al., PMID: 32103185). The disorder is characterized by developmental delay, seizures, and brain atrophy, and in more severe cases, microcephaly and infantile death. Four variants (1 splice, 2 in-frame deletions, and 1 missense) reported in four probands in one publication (PMID: 32103185) are included in this curation. However, only the splice variant, identified in two families in homozygosity or compound heterozygosity, has supportive functional evidence and was scored at full points. The mechanism of pathogenicity is suggested to be partial loss of function (PMID: 32103185) but functional characterization of the missense and in-frame variants is necessary to elucidate the disease mechanism. This gene-disease relationship is also supported by a null zebrafish model that recapitulates the human disorder with microcephaly, increased apoptosis and decreased progenitor cells in the developing telencephalon, suggesting that the brain atrophy in patients reflects neuronal degeneration (PMID: 32103185). Of note, homozygous truncating variants in another member of the exocyst complex, *EXOC8*, have been reported in two unrelated families with a similar clinical disorder involving microcephaly, seizures, and brain atrophy (PMIDs: 32103185, 35460391). In summary, there is moderate evidence supporting the relationship between *EXOC7* and autosomal recessive neurodevelopmental disorder with seizures and brain atrophy. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This gene-disease pair was originally evaluated by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on June 20, 2023. It was reevaluated on October 1, 2026. As a result of this reevaluation, no additional patients were identified, and the classification did not change. The scoring was updated to be consistent with SOP Version 12.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to EXOC7 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001013839.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 11 | 1 | 13 | ||
| missense | 1 | 92 | 6 | 1 | 100 | |
| nonsense | 1 | 2 | 3 | |||
| start loss | 1 | 1 | ||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | 8 | 9 | |||
| Total | 3 | 0 | 104 | 17 | 2 | 126 |
Highest pathogenic variant AF is 0.000035335164
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001013861.1 | 19 | MANE Select | |
| Ensembl | ENSP00000468404.1 | 19 | MANE Select | |
| RefSeq | NP_001138769.1 | 20 | Standard | |
| RefSeq | NP_001138770.1 | 19 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Insulin signaling pathway - Homo sapiens (human)
- Angiopoietin Like Protein 8 Regulatory Pathway
- Arf6 trafficking events
- VxPx cargo-targeting to cilium
- Insulin Pathway
Biological Process
- exocytosis
- protein transport
- regulation of macroautophagy
- regulation of entry of bacterium into host cell
Molecular Function
- protein binding
Cellular Component
- exocyst
- microtubule organizing center
- cytosol
- plasma membrane
- membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000335146
- Coding exons
- 20
- Length
- 40571
- Individuals with no LoFs
- 125719
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 29
- Defined
- 125748
- p
- 0.000115
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.88 | 344 | 457 | 0.753 | 0.0000284 | 4846 |
| Missense (PolyPhen) | 83 | 136.23 | 0.60925 | 1618 | ||
| Synonymous | 1.05 | 176 | 195 | 0.904 | 0.0000135 | 1401 |
| Loss of Function | 3.32 | 18 | 41.0 | 0.439 | 0.00000201 | 467 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000093 | 0.000092 | rare |
| European (Non-Finnish) | 0.00020 | 0.00019 | rare |
| South Asian | 0.000099 | 0.000098 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Component of the exocyst complex involved in the docking of exocytic vesicles with fusion sites on the plasma membrane. In adipocytes, plays a crucial role in targeting SLC2A4 vesicle to the plasma membrane in response to insulin, perhaps directing the vesicle to the precise site of fusion (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.176
Intolerance Scores
- LoFtool
- 0.0265
- RVIS EVS
- -0.93
- RVIS percentile EVS
- 9.61
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- H
- Indispensability pred.
- E
- Indispensability score
- 0.687
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |